Major technology companies raised their artificial intelligence infrastructure spending forecasts in late 2025, deepening investor debate over when those billions will generate returns.

Major media mergers and a sprawling bidding battle for Warner Bros. are redefining how movies and TV are made, financed, and distributed.

Canada lost its measles elimination status in November 2025, a setback that also removes the Americas' region-wide measles-free designation.

Congress passed a stopgap funding bill ending the longest federal shutdown in U.S. history, with a January 30, 2026 funding deadline and health care subsidies still unresolved.

John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for showing quantum behavior can appear in an electric circuit large enough to hold.

The EU's Entry/Exit System began replacing passport stamps with biometric registration for non-EU travelers at Schengen borders on October 12, 2025.

Congress passed a funding bill ending the 43-day U.S. federal government shutdown, the longest in American history, and President Trump signed it into law.

The streaming industry's race for raw subscriber counts is giving way to a focus on profitability, advertising revenue, and bundled services.

The EU's AI Act moves toward its August 2026 deadline for high-risk systems as the Commission proposes postponing some obligations.

Texas, California, Missouri and North Carolina have redrawn congressional districts mid-decade, setting up a high-stakes fight for House control in the November 2026 midterms.

The United States, Canada, and Mexico are in final preparations to host the 2026 FIFA World Cup, the first ever to feature 48 nations across three countries.

Major streaming platforms are rapidly integrating AI tools into production pipelines, forcing a dramatic shift in how films and TV shows are created and distributed.

Major central banks worldwide face mounting pressure as inflation remains above targets, forcing policymakers to delay anticipated interest rate cuts.

The global streaming landscape is undergoing dramatic consolidation in 2026, with major platforms restructuring their content strategies and subscriber models.

Major technology companies including Microsoft, Google, and OpenAI are aggressively rolling out AI agent platforms capable of autonomously completing complex, multi-step tasks.

The NFL's global push intensifies in 2026 as league officials advance concrete plans for permanent international franchises following record overseas game attendance.

Artificial intelligence diagnostic tools are transforming patient care worldwide, with hospitals reporting faster, more accurate disease detection across multiple specialties.

Central banks worldwide face mounting pressure as inflation proves harder to tame than expected, delaying anticipated interest rate cuts into 2026.

International air travel has officially exceeded 2019 pre-pandemic levels, with airports worldwide scrambling to manage unprecedented passenger volumes.

Major central banks worldwide are reassessing their monetary easing timelines as inflation proves more persistent than forecast, rattling equity and bond markets.

Major corporations and governments worldwide continue to pour unprecedented capital into artificial intelligence infrastructure, fundamentally transforming industries and labor markets.

Corporate spending on artificial intelligence infrastructure and tools continues to accelerate in 2026, fundamentally transforming industries from finance to manufacturing.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with new approvals and research expanding their medical applications.

Major technology companies including Microsoft, Google, and OpenAI are aggressively expanding AI agent capabilities, marking a fundamental shift from chatbots to autonomous task-completing systems.

The United States, Canada, and Mexico are ramping up final preparations for the 2026 FIFA World Cup, the largest in the tournament's history.

Major technology companies are committing record-breaking capital expenditures to AI infrastructure, reshaping global business investment patterns heading into 2026.

The 2025-26 NBA season is delivering compelling storylines as young superstars push veteran franchises and the playoff races intensify across both conferences.

Major technology companies including Microsoft, Google, and OpenAI are aggressively rolling out AI agent platforms capable of autonomously completing complex, multi-step tasks.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment, with new data confirming cardiovascular and kidney benefits.

The 2026 FIFA World Cup, hosted across the United States, Canada, and Mexico, is set to become the biggest football tournament ever staged with 48 nations competing.

Opening arguments began in Oakland federal court in a trial where states are seeking up to $1.4 trillion from Meta and sweeping changes to Instagram and Facebook, following two major losses in related cases this year.

International air travel continues breaking post-pandemic records in 2025-2026, pushing airlines and airports to their operational limits worldwide.

Corporate spending on artificial intelligence infrastructure continues to surge in 2026, with major tech firms committing hundreds of billions to data centers and AI development.

Artificial intelligence platforms are accelerating drug discovery timelines from decades to years, reshaping pharmaceutical research in 2025 and into 2026.

Artificial intelligence is transforming pharmaceutical research, slashing drug discovery timelines from decades to years and opening new frontiers in medicine.

Corporate spending on artificial intelligence infrastructure continues to break records in 2026, with tech giants committing hundreds of billions to AI development.

Major central banks worldwide face mounting pressure as persistent inflation and slowing growth complicate long-anticipated interest rate cut timelines.

GLP-1 receptor agonists like semaglutide and tirzepatide continue to transform obesity treatment, cardiovascular care, and healthcare systems worldwide.

Artificial intelligence is revolutionizing pharmaceutical research, compressing drug discovery timelines from decades to years and opening doors to treatments for complex diseases.

A closer look at the ingredients, additives, and ultra-processing in a bag of Cheetos, and what the science actually says about frequent consumption of foods like this.

Major corporations worldwide are dramatically accelerating AI infrastructure spending, fundamentally transforming hiring, operations, and competitive strategy across industries.

Netflix, Disney+, and emerging rivals are reshaping entertainment consumption as the streaming industry undergoes its most competitive phase yet in 2026.

Major technology companies including Microsoft, Google, and OpenAI are aggressively expanding AI agent deployments, marking a fundamental shift from chatbots to autonomous task-completing systems.

Cities and natural sites worldwide are enforcing unprecedented caps on tourist numbers as overtourism pressures reach a breaking point.

Corporate AI spending continues its historic climb in 2026, with major tech firms and enterprises doubling down on artificial intelligence infrastructure and automation.

GLP-1 receptor agonists like semaglutide continue transforming obesity treatment worldwide, with expanded access, new indications, and mounting research reshaping healthcare systems.

Major central banks including the Federal Reserve and ECB are carefully managing interest rate reductions as inflation remains stubbornly above targets in early 2026.

Devastating wildfires are ravaging multiple continents simultaneously, breaking historical records and displacing millions as climate change extends fire seasons and creates more favorable conditions for uncontrolled blazes.

Corporate spending on artificial intelligence infrastructure continues to accelerate in 2026, with tech giants committing hundreds of billions to reshape industries worldwide.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with expanding approvals and growing evidence of broader health benefits.